This is a Validated Antibody Database (VAD) review about Rhesus mon.. IFNG, based on 83 published articles (read how Labome selects the articles), using IFNG antibody in all methods. It is aimed to help Labome visitors find the most suited IFNG antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IFNG synonym: IFN-gamma; interferon gamma

BioLegend
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3b
BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 3b). Front Immunol (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1e
BioLegend IFNG antibody (BioLegend, 502542) was used in flow cytometry on human samples (fig 1e). Cell (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; 1:50; loading ...; fig s10c
BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples at 1:50 (fig s10c). Nature (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 8d
BioLegend IFNG antibody (Biolegend, 4 S.B3) was used in flow cytometry on human samples (fig 8d). Nat Commun (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s3a
BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig s3a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:20; loading ...; fig 1a
BioLegend IFNG antibody (Biolegend, 502536) was used in flow cytometry on human samples at 1:20 (fig 1a). Nat Med (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1j
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 1j). PLoS Pathog (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4a
BioLegend IFNG antibody (Biolegend, 502516) was used in flow cytometry on human samples (fig 4a). Cell (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s3a
BioLegend IFNG antibody (BD Bioscience, 502531) was used in flow cytometry on human samples (fig s3a). J Clin Invest (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 5d
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 5d). Nat Immunol (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 6a
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 6a). Int J Infect Dis (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 3f
BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 3f). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3b
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 3b). J Exp Med (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 2a
BioLegend IFNG antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 2a). Cancer Immunol Res (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2i
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 2i). J Clin Invest (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2c
BioLegend IFNG antibody (BioLegend, 45.B3) was used in flow cytometry on human samples (fig 2c). J Immunol (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2b
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend IFNG antibody (Biolegend, 502511) was used in flow cytometry on human samples (fig 2b). Cell Death Dis (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 1f
BioLegend IFNG antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 1f). Immun Inflamm Dis (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3d
BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 3d). Ann Rheum Dis (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 5
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 5). J Immunol (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s2a
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig s2a). Nature (2017) ncbi
mouse monoclonal (B27)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend IFNG antibody (BioLegend, B27) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1a
In order to detail MAIT cell responses to various microorganisms and cytokines, BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4a
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1a
BioLegend IFNG antibody (BioLegend, 4S. B3) was used in flow cytometry on human samples (fig 1a). Oncotarget (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 3d
In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, BioLegend IFNG antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 3d). Oncoimmunology (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 6b
BioLegend IFNG antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 6b). J Exp Med (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 4b
In order to investigate the role of Vgamma9/Vdelta2 T cells in intestinal IL-22 production, BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 4b). J Immunol (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 2a
BioLegend IFNG antibody (BioLegend, 506518) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend IFNG antibody (BioLegend, 502512) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; Rhesus monkey; loading ...
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on Rhesus monkey samples . PLoS Pathog (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; tbl 1
In order to report the function of CD70-CD27 signaling in patients infected with Epstein-Barr virus, BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (tbl 1). J Exp Med (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; mouse; loading ...; fig 3d
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on mouse samples (fig 3d). J Clin Invest (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4a
In order to investigate the roles of CD16+ monocytes in T-cell activation and B-cell responses in systemic lupus erythematosus, BioLegend IFNG antibody (Biolegend, 502506) was used in flow cytometry on human samples (fig 4a). Front Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3d
BioLegend IFNG antibody (Biolegend, 502511) was used in flow cytometry on human samples (fig 3d). Cell (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3d
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 3d). J Exp Med (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 2
BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 2). PLoS Pathog (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2e
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 2e). J Clin Invest (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig s9d
In order to explore the role of exhausted CD8 positive CXCR5 positive T cells in mice chronically infected with lymphocytic choriomeningitis virus, BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig s9d). Nature (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 7
In order to study the functions of WASp knock out natural killer cells, BioLegend IFNG antibody (Biolegend, 502520) was used in flow cytometry on human samples (fig 7). Sci Rep (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2a
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig s1d
BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig s1d). Eur J Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; mouse; loading ...; fig 6g
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BioLegend IFNG antibody (BioLegend, B27) was used in flow cytometry on mouse samples (fig 6g). Science (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 6c
BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 6c). J Biol Chem (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; mouse; fig 3
BioLegend IFNG antibody (Biolegend, 502530) was used in flow cytometry on mouse samples (fig 3). Oncoimmunology (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4b
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 4b). Clin Cancer Res (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend IFNG antibody (biolegend, 4S.B3) was used in flow cytometry on human samples (fig 3a). J Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2a
BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 2a). PLoS Pathog (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 4c
In order to examine if pregnancy-related changes in disease activity are associated with changes in T cell populations, BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 4c). Arthritis Res Ther (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig s2a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples (fig s2a). J Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4e
BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 4e). J Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 1
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFNG antibody (BioLegend, 4S . B3) was used in flow cytometry on human samples . Thromb Res (2015) ncbi
mouse monoclonal (B27)
  • immunocytochemistry; human; fig 6
BioLegend IFNG antibody (BioLegend, B27) was used in immunocytochemistry on human samples (fig 6). J Hematol Oncol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:200; fig 6
BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples at 1:200 (fig 6). Nat Commun (2015) ncbi
mouse monoclonal (MD-1)
  • immunohistochemistry - paraffin section; human; fig s4
BioLegend IFNG antibody (BioLegend, MD-1) was used in immunohistochemistry - paraffin section on human samples (fig s4). Mol Cancer (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 3
BioLegend IFNG antibody (Biolegend, 502535) was used in flow cytometry on human samples (fig 3). Scand J Immunol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 4c
BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 4c). J Immunol Res (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFNG antibody (Biolegend, 502533) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 2
BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 2). Cancer Immunol Res (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 2 ul/test
In order to analyze mucosal pinch biopsies collected predominantly during colonoscopies, BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples at 2 ul/test. J Immunol Methods (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 3
BioLegend IFNG antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (MD-1)
  • dot blot; human; tbl s1
In order to use polydimethylsiloxane microchambers to co-detect 42 immune effector proteins secreted from a single LPS-stimulation macrophage, BioLegend IFNG antibody (Biolegend, 507502) was used in dot blot on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 4
BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 4). Nat Immunol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 10 mg/ml; fig 3
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples at 10 mg/ml (fig 3). J Surg Res (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples . Nat Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:40
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples at 1:40. Nat Med (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; 1:40
BioLegend IFNG antibody (BioLegend, B27) was used in flow cytometry on human samples at 1:40. Nat Med (2014) ncbi
mouse monoclonal (4S.B3)
BioLegend IFNG antibody (BioLegend, 4S.B3) was used . J Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 2
BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 2). J Infect Dis (2015) ncbi
mouse monoclonal (4S.B3)
BioLegend IFNG antibody (Biolegend, 4S.B3) was used . PLoS ONE (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 2
BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 2). J Infect Dis (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 5a
BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 5a). J Invest Dermatol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples . J Virol (2014) ncbi
mouse monoclonal (4S.B3)
BioLegend IFNG antibody (BioLegend, 4S.B3) was used . Cell Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BioLegend IFNG antibody (BioLegend, B27) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BioLegend IFNG antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples . J Cell Physiol (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFNG antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples . Clin Cancer Res (2013) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BioLegend IFNG antibody (Biolegend, B27) was used in flow cytometry on human samples . Tuberculosis (Edinb) (2013) ncbi
Articles Reviewed
  1. Thauland T, Pellerin L, Ohgami R, Bacchetta R, Butte M. Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome. Front Immunol. 2019;10:753 pubmed publisher
  2. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed publisher
  3. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed publisher
  4. Aulicino A, Rue Albrecht K, Preciado Llanes L, Napolitani G, Ashley N, Cribbs A, et al. Invasive Salmonella exploits divergent immune evasion strategies in infected and bystander dendritic cell subsets. Nat Commun. 2018;9:4883 pubmed publisher
  5. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  6. Wagner D, Amini L, Wendering D, Burkhardt L, Akyüz L, Reinke P, et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2019;25:242-248 pubmed publisher
  7. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed publisher
  8. Bradley T, Peppa D, Pedroza Pacheco I, Li D, Cain D, Henao R, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. 2018;175:387-399.e17 pubmed publisher
  9. Levin M, Kroehl M, Johnson M, Hammes A, Reinhold D, Lang N, et al. Th1 memory differentiates recombinant from live herpes zoster vaccines. J Clin Invest. 2018;128:4429-4440 pubmed publisher
  10. Clayton K, Collins D, Lengieza J, Ghebremichael M, Dotiwala F, Lieberman J, et al. Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat Immunol. 2018;19:475-486 pubmed publisher
  11. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  12. Stanko K, Iwert C, Appelt C, Vogt K, Schumann J, Strunk F, et al. CD96 expression determines the inflammatory potential of IL-9-producing Th9 cells. Proc Natl Acad Sci U S A. 2018;115:E2940-E2949 pubmed publisher
  13. Li N, van Unen V, Höllt T, Thompson A, van Bergen J, Pezzotti N, et al. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. J Exp Med. 2018;215:1383-1396 pubmed publisher
  14. Oei V, Siernicka M, Graczyk Jarzynka A, Hoel H, Yang W, Palacios D, et al. Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors. Cancer Immunol Res. 2018;6:467-480 pubmed publisher
  15. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  16. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed publisher
  17. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  18. Hydes T, Noll A, Salinas Riester G, Abuhilal M, Armstrong T, Hamady Z, et al. IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells. Immun Inflamm Dis. 2018;6:34-46 pubmed publisher
  19. Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77:63-69 pubmed publisher
  20. Zhang X, Lian X, Dai Z, Zheng H, Chen X, Zheng Y. ?3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells. J Immunol. 2017;199:2030-2042 pubmed publisher
  21. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  22. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  23. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  24. Lu G, Zhang X, Shen L, Qiao Q, Li Y, Sun J, et al. CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy. PLoS ONE. 2017;12:e0178352 pubmed publisher
  25. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  26. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed publisher
  27. Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D, et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841 pubmed publisher
  28. Tyler C, McCarthy N, Lindsay J, Stagg A, Moser B, Eberl M. Antigen-Presenting Human γδ T Cells Promote Intestinal CD4+ T Cell Expression of IL-22 and Mucosal Release of Calprotectin. J Immunol. 2017;198:3417-3425 pubmed publisher
  29. Klinker M, Marklein R, Lo Surdo J, Wei C, Bauer S. Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci U S A. 2017;114:E2598-E2607 pubmed publisher
  30. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  31. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  32. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  33. Izawa K, Martin E, Soudais C, Bruneau J, Boutboul D, Rodriguez R, et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J Exp Med. 2017;214:73-89 pubmed publisher
  34. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  35. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  36. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed publisher
  37. Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, et al. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 2016;213:2065-80 pubmed publisher
  38. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  39. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  40. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed publisher
  41. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed publisher
  42. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  43. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed publisher
  44. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed publisher
  45. Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed publisher
  46. Fisher J, Flutter B, Wesemann F, Frosch J, Rossig C, Gustafsson K, et al. Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells. Oncoimmunology. 2016;5:e1025194 pubmed
  47. Vallera D, Felices M, McElmurry R, McCullar V, Zhou X, Schmohl J, et al. IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function. Clin Cancer Res. 2016;22:3440-50 pubmed publisher
  48. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  49. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  50. Tham M, Schlör G, Yerly D, Mueller C, Surbek D, Villiger P, et al. Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis. Arthritis Res Ther. 2016;18:26 pubmed publisher
  51. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  52. Simonetta F, Pradier A, Bosshard C, Masouridi Levrat S, Chalandon Y, Roosnek E. NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin. J Immunol. 2015;195:4712-20 pubmed publisher
  53. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  54. Zhu F, Qiao J, Cao J, Sun H, Wu Q, Sun Z, et al. Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocytopenia (ITP). Thromb Res. 2015;136:797-802 pubmed publisher
  55. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed publisher
  56. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  57. Chang D, Moniz R, Xu Z, Sun J, Signoretti S, Zhu Q, et al. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo. Mol Cancer. 2015;14:119 pubmed publisher
  58. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  59. Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli R, et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res. 2015;2015:253191 pubmed publisher
  60. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  61. Bradley S, Chen Z, Melendez B, Talukder A, Khalili J, Rodríguez Cruz T, et al. BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma. Cancer Immunol Res. 2015;3:602-9 pubmed publisher
  62. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed publisher
  63. Steindor M, Nkwouano V, Mayatepek E, Mackenzie C, Schramm D, Jacobsen M. Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients. PLoS ONE. 2015;10:e0119737 pubmed publisher
  64. Lu Y, Xue Q, Eisele M, Sulistijo E, Brower K, Han L, et al. Highly multiplexed profiling of single-cell effector functions reveals deep functional heterogeneity in response to pathogenic ligands. Proc Natl Acad Sci U S A. 2015;112:E607-15 pubmed publisher
  65. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed publisher
  66. Setoguchi R, Matsui Y, Mouri K. mTOR signaling promotes a robust and continuous production of IFN-γ by human memory CD8+ T cells and their proliferation. Eur J Immunol. 2015;45:893-902 pubmed publisher
  67. Zhang P, Lu X, Tao K, Shi L, Li W, Wang G, et al. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. J Surg Res. 2015;194:107-13 pubmed publisher
  68. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed publisher
  69. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed publisher
  70. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed publisher
  71. Bacher P, Kniemeyer O, Teutschbein J, Thön M, Vödisch M, Wartenberg D, et al. Identification of immunogenic antigens from Aspergillus fumigatus by direct multiparameter characterization of specific conventional and regulatory CD4+ T cells. J Immunol. 2014;193:3332-43 pubmed publisher
  72. Madhavi V, Ana Sosa Batiz F, Jegaskanda S, Center R, Winnall W, Parsons M, et al. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy. J Infect Dis. 2015;211:529-38 pubmed publisher
  73. Jin J, Zhang W, Wong K, Kwak M, van Driel I, Yu Q. Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS ONE. 2014;9:e104753 pubmed publisher
  74. Tchakoute C, Hesseling A, Kidzeru E, Gamieldien H, Passmore J, Jones C, et al. Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants. J Infect Dis. 2015;211:338-46 pubmed publisher
  75. Chandran P, Keller A, Weinmann L, Seida A, Braun M, Andreev K, et al. The TGF-?-inducible miR-23a cluster attenuates IFN-? levels and antigen-specific cytotoxicity in human CD8? T cells. J Leukoc Biol. 2014;96:633-45 pubmed publisher
  76. Kistowska M, Meier B, Proust T, Feldmeyer L, Cozzio A, Kuendig T, et al. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients. J Invest Dermatol. 2015;135:110-118 pubmed publisher
  77. Payne T, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift N, et al. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. J Virol. 2014;88:9514-28 pubmed publisher
  78. Jiang B, Wu X, Li X, Yang X, Zhou Y, Yan H, et al. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Cell Immunol. 2014;290:10-20 pubmed publisher
  79. Lanteri M, Diamond M, Law J, Chew G, Wu S, Inglis H, et al. Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection. PLoS ONE. 2014;9:e92134 pubmed publisher
  80. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  81. Galindo Albarrán A, Ramirez Pliego O, Labastida Conde R, Melchy Pérez E, Liquitaya Montiel A, Esquivel Guadarrama F, et al. CD43 signals prepare human T cells to receive cytokine differentiation signals. J Cell Physiol. 2014;229:172-80 pubmed
  82. Wiernik A, Foley B, Zhang B, Verneris M, Warlick E, Gleason M, et al. Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clin Cancer Res. 2013;19:3844-55 pubmed publisher
  83. Marin N, Paris S, Rojas M, Garcia L. Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB. Tuberculosis (Edinb). 2013;93:155-66 pubmed publisher